Hidden diabetes risk from common steroids revealed by continuous monitors
NCT ID NCT07190378
Summary
This study aims to better understand and detect steroid-induced diabetes, a common side effect of steroid medications used for conditions like arthritis and cancer. Researchers will monitor 250 adults starting steroid treatment using continuous glucose sensors for 14 days to identify who develops diabetes and what patterns emerge. The goal is to improve early detection methods since current diabetes tests may miss steroid-related blood sugar problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
Warsaw, Warsaw, 02-097, Poland
Conditions
Explore the condition pages connected to this study.